NDEGWA M NJUGUNA

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TACOMA, WA NPI 1851577522

General Payments — all program years on this page

$3,686.68

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 80
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $495.54 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $395.5920
Education $99.951

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,846.2211
2019 $416.5320
2020 $123.223
2021 $172.647
2022 $400.059
2023 $232.489
2024 $495.5421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078834285 Janssen Biotech, Inc. $28.09 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089463118 Daiichi Sankyo Inc. $18.46 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091965918 Ipsen Biopharmaceuticals, Inc $26.39 09/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105129879 ABBVIE INC. $8.99 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105129881 ABBVIE INC. $7.63 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105129883 ABBVIE INC. $24.85 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105129885 ABBVIE INC. $10.06 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105129887 ABBVIE INC. $16.89 09/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105129889 ABBVIE INC. $16.76 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105129891 ABBVIE INC. $16.71 11/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105129893 ABBVIE INC. $99.95 12/09/2024 Education Undisputed 01/23/2026 View at CMS
1105452775 AstraZeneca Pharmaceuticals LP $16.96 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105803319 AstraZeneca Pharmaceuticals LP $24.98 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110769559 Eisai Inc. $22.86 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120859323 BeiGene USA, Inc. $16.11 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133079459 Genentech USA, Inc. $20.62 03/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133079463 Genentech USA, Inc. $23.70 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135176105 Lilly USA, LLC $17.87 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139717180 GENZYME CORPORATION $31.31 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141780491 Merck Sharp & Dohme LLC $14.72 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144964228 Takeda Pharmaceuticals U.S.A., Inc. $31.63 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.